Cell and Gene Manufacturing and Logistics

  1. Why Shipping System Qualification Matters In Advanced Therapies 12/2/2025

    Ensuring the integrity of advanced therapies requires documented evidence of robust shipping processes. Qualification is essential for compliance and maintaining continuity across the supply chain.

  2. Built Or Bought? Why Biotechs Are Outsourcing Supply Chain Infrastructure 12/2/2025

    Scaling advanced therapies requires navigating extreme logistics and regulatory hurdles. Learn why moving to a flexible, outsourced model is essential for freeing capital and mitigating global risk.

  3. New Technology Platforms Being Developed 12/2/2025

    Emerging tools and technology platforms are transforming drug development, enabling faster discovery, improved scalability, and greater precision across biologics, advanced therapies, and data-driven manufacturing processes.

  4. Model-Driven Genetic Design And Bioprocess Optimization Across Modalities 12/2/2025

    Traditional biomanufacturing relies too heavily on trial and error. By integrating AI and mechanistic models into early design, developers can overcome productivity limits and accelerate timelines for complex therapeutic modalities.

  5. Could Chicken Wisdom Help Cell Therapies Spread Wings? 12/2/2025

    Evolutionary theory could explain why cell therapies have hit a slump, and help developers get out of it, too.

  6. A Better Way For Closed-System Processing In Cell Therapy 12/1/2025

    Small changes in aseptic processing can yield major operational improvements. Streamlining closed-system connections helps reduce contamination risks, supports scalability, and lowers manufacturing costs.

  7. 5 Key Questions On Implementing Pharma 4.0™ Solutions For Fill-Finish 12/1/2025

    Pharma 4.0 leverages IoT, AI, and automation to enhance drug quality. Evaluate your fill-finish line readiness by considering five key questions on modularity, high-risk process automation, and data integration.

  8. Choosing The Right CDMO Partner For Your Biopharma Molecule 12/1/2025

    Selecting the right CDMO is critical for biopharma success. The ideal partner offers end-to-end capabilities, scientific expertise, quality culture, agility, and transparent collaboration from concept to commercialization.

  9. Phosphitylating And Phosphorylating Agents 11/25/2025

    Explore essential phosphitylating and phosphorylating agents used in API synthesis and oligonucleotide preparation for cell and gene therapy applications.

  10. Formulation And Delivery Considerations For Cell And Gene Therapies 11/25/2025

    How can we ensure cell and gene therapies are truly transformative for patients? Success depends on the right combination of formulation, preparation, and delivery.